Results 191 to 200 of about 35,531 (245)

Gastrointestinal Bleeding From Acquired Factor X Deficiency due to Light Chain Amyloidosis. [PDF]

Gastro Hep Adv
Liu KS, Liu X, Blaney E.
europepmc   +1 more source

Metabolomics and machine learning approaches for diagnostic biomarkers screening in systemic light chain amyloidosis. [PDF]

Ann Hematol
Xie W, Lai Z, Wang Q, Wang W, Wang J, Liu H, Liang Z, Dong Y.   +7 more
europepmc   +1 more source

Diagnostic pathways, cardiac manifestations and outcomes in light chain amyloidosis: analysis of a US claims database. [PDF]

Open Heart
Lyons G, Thompson J, Lousada I, Catini J, Manwani R, Maurer MS.   +5 more
europepmc   +1 more source

MCV/Q, Medical College of Virginia Quarterly, Vol. 10 No. 2 [PDF]

, 1974

core   +1 more source

Development and validation of an early prediction model for cardiac death risk in patients with light chain amyloidosis: a multicenter study. [PDF]

Cardiooncology
Pang N, Tian Y, Chi H, Fu X, Li X, Wang S, Pan F, Wang D, Xu L, Luo J, Liu A, Liu X.   +11 more
europepmc   +1 more source

Diastolic Dysfunction Unveiling Cardiac Light-Chain Amyloidosis: A Case Report. [PDF]

Med Res Arch
Saha S, Mondal R, Deb S, Sarkar B, Benito-León J.   +4 more
europepmc   +1 more source

Predicting survival in light chain amyloidosis

Haematologica, 2019
Giovanni Palladini, Paolo Milani, Giampaolo Merlini   +2 more
doaj   +1 more source

Impact of the Addition of Daratumumab to the Frontline Treatment of Patients with Immunoglobulin Light-Chain Amyloidosis: A Single-Centre Experience. [PDF]

Cancers (Basel)
Alejo E, Agulló C, Puertas B, Eiros R, Rey-Búa B, Barnés C, Rodríguez-González M, López-Corral L, Santos-Briz Á, Escalante F, Pérez-García ML, Jiménez-Cabrera S, Gutiérrez NC, Puig N, Mateos MV, González-Calle V.   +15 more
europepmc   +1 more source

Healthcare resource utilization and costs in amyloid light-chain amyloidosis: a real-world study using US claims data

, 2018
Tiffany P. Quock, Tingjian Yan, Eunice Chang, Spencer Guthrie, Michael S. Broder   +4 more
openalex   +1 more source

Rapid identification of daratumumab interference with M-protein detection using MALDI-TOF mass spectrometry: a case study involving renal light chain amyloidosis. [PDF]

Pract Lab Med
Luo HL, Xu A, Ji L.
europepmc   +1 more source